Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction
Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we inve...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 48; no. 2; pp. 225 - 231 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.08.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week–old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects. |
---|---|
AbstractList | Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week–old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects. Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week-old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects.Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week-old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects. |
Author | Shimosawa, Tatsuo Ando, Katsuyuki Matsui, Hiromitsu Liu, Jing Ogura, Sayoko Fujita, Toshiro Wang, Hong Kaneko, Tomoyo Uetake, Yuzaburo |
AuthorAffiliation | From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan |
AuthorAffiliation_xml | – name: From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan |
Author_xml | – sequence: 1 givenname: Hiromitsu surname: Matsui fullname: Matsui, Hiromitsu organization: From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan – sequence: 2 givenname: Tatsuo surname: Shimosawa fullname: Shimosawa, Tatsuo – sequence: 3 givenname: Yuzaburo surname: Uetake fullname: Uetake, Yuzaburo – sequence: 4 givenname: Hong surname: Wang fullname: Wang, Hong – sequence: 5 givenname: Sayoko surname: Ogura fullname: Ogura, Sayoko – sequence: 6 givenname: Tomoyo surname: Kaneko fullname: Kaneko, Tomoyo – sequence: 7 givenname: Jing surname: Liu fullname: Liu, Jing – sequence: 8 givenname: Katsuyuki surname: Ando fullname: Ando, Katsuyuki – sequence: 9 givenname: Toshiro surname: Fujita fullname: Fujita, Toshiro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16818802$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1uEzEUhS1URNPCKyCLBbsZbI_HnumKKBSCVKkRPwJWlse-0xgm49T2ULLi1XGSokqs8Ma-1neOdM85QyejHwGhF5SUlAr6itBy-W1VknxYxQSVJW8qyUrTPUIzWjNe8FpUJ2hGaMuLltKvp-gsxu-EUM65fIJOqWho0xA2Q79XwScwyf0EfNn3-YV9j1c-6RjdtMHzG-3GmHBaA17uthASjHEPL3SwThv8Zhf7acwGfrzA8xi9cXo_4C8urfEH0Efv61-7Gxjxxy0YBzH_2-mgeYoe93qI8Oz-Pkef315-WiyLq-t37xfzq8JwUvGCEca11ZqzrrZS8labribQyE53UuZdWKMrLUBaq6nlnbaMCdMSyzomKllX5-jl0Xcb_O0EMamNiwaGQY_gp6hEI-pWiiqDz-_BqduAVdvgNjrs1N_IMnBxBEzwMQboHxCi9v0oQlXuRz30ow79KNNl8et_xMalQ14paDf8nwU_Wtz5IUGIP4bpDoJagx7S-qDgTDQ5MSJIk6eC7Huv_gDbkqng |
CitedBy_id | crossref_primary_10_1007_s10157_010_0350_8 crossref_primary_10_1016_j_mehy_2018_08_001 crossref_primary_10_3945_ajcn_111_013094 crossref_primary_10_1016_j_toxrep_2025_101936 crossref_primary_10_1371_journal_pone_0232413 crossref_primary_10_2169_naika_97_37a crossref_primary_10_1007_s11906_013_0358_z crossref_primary_10_1007_s10554_023_02914_x crossref_primary_10_3389_fphar_2021_756671 crossref_primary_10_3109_10715762_2014_991724 crossref_primary_10_1016_j_mencom_2007_06_010 crossref_primary_10_1186_s40659_021_00365_z crossref_primary_10_1016_j_semnephrol_2013_04_008 crossref_primary_10_2169_naika_96_1827 crossref_primary_10_1159_000472259 crossref_primary_10_3109_07853890_2012_671538 crossref_primary_10_1002_bmc_970 crossref_primary_10_1016_j_neuro_2023_09_007 crossref_primary_10_1016_j_mvr_2012_09_005 crossref_primary_10_1177_0148607113491781 crossref_primary_10_1016_j_freeradbiomed_2009_04_030 crossref_primary_10_1038_hr_2011_63 crossref_primary_10_1093_gerona_63_10_1034 crossref_primary_10_3109_10641960903254521 crossref_primary_10_1111_jch_13207 crossref_primary_10_1017_jns_2013_4 crossref_primary_10_1080_13813450802535978 crossref_primary_10_2169_naika_96_46a crossref_primary_10_1097_JCMA_0000000000000103 crossref_primary_10_1038_hr_2016_127 crossref_primary_10_1253_jjcsc_19_1_3 crossref_primary_10_1016_j_mehy_2011_09_028 crossref_primary_10_1093_ajh_hpy101 crossref_primary_10_1007_s00395_009_0014_6 crossref_primary_10_1152_ajprenal_00123_2014 crossref_primary_10_1038_hr_2010_46 crossref_primary_10_4162_nrp_2014_8_4_417 crossref_primary_10_1186_s12944_015_0002_9 crossref_primary_10_1097_HJH_0b013e328300a232 crossref_primary_10_31083_j_fbs1504014 crossref_primary_10_3390_nu12051206 crossref_primary_10_1080_07315724_2008_10719740 crossref_primary_10_1093_eurheartj_ehac313 crossref_primary_10_1016_j_foodchem_2023_137408 crossref_primary_10_24018_ejmed_2023_5_4_1755 crossref_primary_10_3109_08037051_2011_649537 crossref_primary_10_1590_S1677_55382012000200011 crossref_primary_10_2169_naika_97_1979 crossref_primary_10_1111_j_1440_1681_2011_05510_x crossref_primary_10_1146_annurev_physiol_010908_163241 crossref_primary_10_31083_j_jin2204098 crossref_primary_10_1038_ajh_2007_9 crossref_primary_10_1111_j_1440_1681_2009_05198_x crossref_primary_10_1111_j_1748_1716_2010_02248_x crossref_primary_10_3317_jraas_2006_029 crossref_primary_10_1186_s42826_023_00179_y |
Cites_doi | 10.1038/nm1119 10.1074/jbc.M102124200 10.1152/ajpcell.00230.2003 10.1164/ajrccm.154.4.8887607 10.1161/circ.62.4.7408148 10.1016/S0735-1097(01)01230-X 10.1161/01.CIR.58.6.1072 10.1161/01.hyp.0000032031.30374.32 10.1016/S0735-1097(03)00471-6 10.1001/jama.289.2.194 10.1016/S0022-2828(03)00080-4 10.1161/01.hyp.6.2.184 10.1007/978-1-4615-5385-4_10 10.1161/circ.104.24.2967 10.1016/0735-1097(91)90774-4 10.1097/00004872-200018010-00016 10.1161/hyp.30.6.1628 10.1016/S0735-1097(98)00101-6 10.1152/ajpheart.00549.2001 10.1161/circ.69.3.6362906 10.1172/JCI108522 10.1161/01.atv.21.4.489 10.1161/01.hyp.0000118017.02160.fa 10.1152/ajpheart.00047.2004 10.1210/jc.2004-0305 10.1161/01.hyp.0000178572.63064.73 10.1097/00005344-200106000-00010 10.1038/sj.jhh.1000893 10.1161/circ.97.16.1536 10.1159/000086411 10.1016/j.amjhyper.2003.08.003 10.1161/01.hyp.0000138070.47616.9d 10.1056/NEJMoa032566 10.1161/01.hyp.0000094557.36656.d0 10.1161/01.cir.0000091084.46500.bb 10.1161/01.RES.22.1.11 10.1161/01.hyp.24.1.77 10.1161/res.85.4.357 10.1038/ki.1983.220 10.1056/NEJM200101043440101 10.1161/circ.101.15.1854 10.1161/01.hyp.6.4.475 10.1016/1071-9164(95)90024-1 10.1161/01.cir.0000018605.14470.dd |
ContentType | Journal Article |
Copyright | 2006 American Heart Association, Inc. |
Copyright_xml | – notice: 2006 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/01.HYP.0000232617.48372.cb |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 231 |
ExternalDocumentID | 16818802 10_1161_01_HYP_0000232617_48372_cb 00004268-200608000-00014 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP CITATION ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW RHF 7X8 |
ID | FETCH-LOGICAL-c4034-2024adaa42b5d7749acb50e87bab7718828a3a6e7dda1d4bad226c90d2b263753 |
ISSN | 0194-911X 1524-4563 |
IngestDate | Fri Jul 11 00:48:43 EDT 2025 Wed Feb 19 01:46:23 EST 2025 Thu Apr 24 23:09:11 EDT 2025 Tue Jul 01 04:30:40 EDT 2025 Fri May 16 03:51:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4034-2024adaa42b5d7749acb50e87bab7718828a3a6e7dda1d4bad226c90d2b263753 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16818802 |
PQID | 68659763 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_68659763 pubmed_primary_16818802 crossref_primary_10_1161_01_HYP_0000232617_48372_cb crossref_citationtrail_10_1161_01_HYP_0000232617_48372_cb wolterskluwer_health_00004268-200608000-00014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-August 2006-08-00 2006-Aug 20060801 |
PublicationDateYYYYMMDD | 2006-08-01 |
PublicationDate_xml | – month: 08 year: 2006 text: 2006-August |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2006 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 16818803 - Hypertension. 2006 Aug;48(2):201-2 |
References_xml | – ident: e_1_3_2_27_2 doi: 10.1038/nm1119 – ident: e_1_3_2_32_2 doi: 10.1074/jbc.M102124200 – ident: e_1_3_2_34_2 doi: 10.1152/ajpcell.00230.2003 – ident: e_1_3_2_39_2 doi: 10.1164/ajrccm.154.4.8887607 – ident: e_1_3_2_22_2 doi: 10.1161/circ.62.4.7408148 – ident: e_1_3_2_6_2 doi: 10.1016/S0735-1097(01)01230-X – ident: e_1_3_2_21_2 doi: 10.1161/01.CIR.58.6.1072 – ident: e_1_3_2_26_2 doi: 10.1161/01.hyp.0000032031.30374.32 – ident: e_1_3_2_31_2 doi: 10.1016/S0735-1097(03)00471-6 – ident: e_1_3_2_7_2 doi: 10.1001/jama.289.2.194 – ident: e_1_3_2_28_2 doi: 10.1016/S0022-2828(03)00080-4 – ident: e_1_3_2_37_2 doi: 10.1161/01.hyp.6.2.184 – ident: e_1_3_2_4_2 doi: 10.1007/978-1-4615-5385-4_10 – ident: e_1_3_2_12_2 doi: 10.1161/circ.104.24.2967 – ident: e_1_3_2_15_2 doi: 10.1016/0735-1097(91)90774-4 – ident: e_1_3_2_17_2 doi: 10.1097/00004872-200018010-00016 – ident: e_1_3_2_18_2 doi: 10.1161/hyp.30.6.1628 – ident: e_1_3_2_9_2 doi: 10.1016/S0735-1097(98)00101-6 – ident: e_1_3_2_30_2 doi: 10.1152/ajpheart.00549.2001 – ident: e_1_3_2_36_2 doi: 10.1161/circ.69.3.6362906 – ident: e_1_3_2_23_2 doi: 10.1172/JCI108522 – ident: e_1_3_2_33_2 doi: 10.1161/01.atv.21.4.489 – ident: e_1_3_2_44_2 doi: 10.1161/01.hyp.0000118017.02160.fa – ident: e_1_3_2_24_2 doi: 10.1152/ajpheart.00047.2004 – ident: e_1_3_2_40_2 doi: 10.1210/jc.2004-0305 – ident: e_1_3_2_14_2 doi: 10.1161/01.hyp.0000178572.63064.73 – ident: e_1_3_2_20_2 doi: 10.1097/00005344-200106000-00010 – ident: e_1_3_2_3_2 doi: 10.1038/sj.jhh.1000893 – ident: e_1_3_2_10_2 doi: 10.1161/circ.97.16.1536 – ident: e_1_3_2_41_2 doi: 10.1159/000086411 – ident: e_1_3_2_19_2 doi: 10.1016/j.amjhyper.2003.08.003 – ident: e_1_3_2_38_2 doi: 10.1161/01.hyp.0000138070.47616.9d – ident: e_1_3_2_5_2 doi: 10.1056/NEJMoa032566 – ident: e_1_3_2_8_2 doi: 10.1161/01.hyp.0000094557.36656.d0 – ident: e_1_3_2_25_2 doi: 10.1161/01.cir.0000091084.46500.bb – ident: e_1_3_2_2_2 doi: 10.1161/01.RES.22.1.11 – ident: e_1_3_2_13_2 doi: 10.1161/01.hyp.24.1.77 – ident: e_1_3_2_29_2 doi: 10.1161/res.85.4.357 – ident: e_1_3_2_35_2 doi: 10.1038/ki.1983.220 – ident: e_1_3_2_42_2 doi: 10.1056/NEJM200101043440101 – ident: e_1_3_2_11_2 doi: 10.1161/circ.101.15.1854 – ident: e_1_3_2_1_2 doi: 10.1161/01.hyp.6.4.475 – ident: e_1_3_2_16_2 doi: 10.1016/1071-9164(95)90024-1 – ident: e_1_3_2_43_2 doi: 10.1161/01.cir.0000018605.14470.dd – reference: 16818803 - Hypertension. 2006 Aug;48(2):201-2 |
SSID | ssj0014447 |
Score | 2.1542542 |
Snippet | Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 225 |
SubjectTerms | Animals Blood Pressure - drug effects Body Weight - drug effects Dietary Supplements Disease Models, Animal Echocardiography Heart Ventricles - metabolism Heart Ventricles - pathology Heart Ventricles - physiopathology Hypertension - complications Hypertension - diet therapy Hypertension - physiopathology Male NADPH Oxidases - metabolism Organ Size - drug effects Potassium Chloride - administration & dosage Potassium, Dietary - therapeutic use Rats Rats, Inbred Dahl Reactive Oxygen Species - metabolism Sodium Chloride, Dietary Ventricular Dysfunction, Left - complications Ventricular Dysfunction, Left - physiopathology Ventricular Dysfunction, Left - prevention & control |
Title | Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-200608000-00014 https://www.ncbi.nlm.nih.gov/pubmed/16818802 https://www.proquest.com/docview/68659763 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAIIW6DcvUDb1VK4rpOwhuCTRWsY0it6J4s3woV0KA21S4v_BF-LMeXXKYNMXiJKqeOo3xfjs_nnHOM0AspiZKZSCKTgVyF-Xoe5SI1kVIENJCZZ1LZROHxPhtN6bvZcNbp_GpFLW1K2VenF-aV_A-q0Aa42izZf0C2vig0wG_AF46AMBwvhfGBL7Jgg398XIaLXy5KcIgXNuj4M8j-tUtW7H0BvbmqotWVo4Xq6ZO1ndeq-A7RQOXXZ8Gh9Fcvjk_gJno2LROUNbRrX3S27dqO6hEcobK3doneByGZ434vydO8tewwFuV643fMXqyK74vSb8Diq0UCf9biyLm1E_u_ojo1NaXw0USHm1MBfKjPfArr3qMiTMWtlYysWskIxpfQCBw6b_DMBW3BYtOsxUzSNr8-ifr8tMASl-rQHx0euIqV4EeC69a35fRJX8lmMqwCAPY_8N3p3h6f7MwmV9BVAiLEWtH3H5tvVJS67evqOwwlbWGsl38e6az7c07T3EA3jwobJrH-6rIkWr7O5Da6FUQKfu0Zdwd1zPIuujYOYRj30M-GeNgTDxdzXBMPB-JhIB5uEw8H4uEW8V7hFu2wpR2uaIc97XCgHa5pdx9Nd3cmb0ZR2MkjUjQeUHhpCRVaCErkUIPgyIWSw9hkqRQyBe8IZL8YCGZSrUWiqRQaVIHKY00kYQNQ1Ntoa1kszUOETcq0YTrWimU0ESbXKXSXMmNqSObxsIvy6gFzFcrc291WvnEnd1nC44QDOLwBhztwuJJdNKj7_vDFXi7V63mFIwfbbD-4iaUpNmvOMgZ6nQ266IGHt7kqy2whRNJF0Rm8uc9-dsOA7-zMHbOizpV_SOijv471GF1v3q0naKtcbcxT8JtL-czR9zcHpcQr |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protective+effect+of+potassium+against+the+hypertensive+cardiac+dysfunction%3A+association+with+reactive+oxygen+species+reduction&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Matsui%2C+Hiromitsu&rft.au=Shimosawa%2C+Tatsuo&rft.au=Uetake%2C+Yuzaburo&rft.au=Wang%2C+Hong&rft.date=2006-08-01&rft.issn=1524-4563&rft.eissn=1524-4563&rft.volume=48&rft.issue=2&rft.spage=225&rft_id=info:doi/10.1161%2F01.HYP.0000232617.48372.cb&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |